Abstract 7899: BGB-21447, a next generation Bcl-2 inhibitor, shows high potential in Bcl-2 overexpressing B cell non-Hodgkin lymphomas (NHL) cancers in preclinical studies
Year: 2026
Type: conference-abstract
Source: Cancer Research
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148858714
Cites:
Cited by:
Related to:
